Alinamin F Side Effects

Common Alinamin F Side Effects

The most commonly reported Alinamin F side effects are:
Side Effect (3)

If you have experienced a side effect listed above, you can check a box to report it.

➢ More

If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Alinamin F Side Effects Reported to FDA

The following Alinamin F reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

The appearance of Alinamin F on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Hepatitis Acute
This is a report of a 75-year-old female patient (weight: NA) from JAPAN, suffering from the following symptoms/conditions: cervicobrachial syndrome,osteoporosis,diabetes mellitus,cerebrovascular accident prophylaxis, who was treated with Alinamin F (fursultiamine Hydrochloride (+) Riboflavin) (dosage: NA, start time: Oct 15, 2005), combined with:
  • Fosamax
  • Glucobay
  • Aspirin
  • Metformin Hcl
  • Januvia
  • Lendormin
  • Amaryl
  • Norvasc
and developed a serious reaction and side effect(s). The consumer presented with:
  • Hepatitis Acute
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Alinamin F (fursultiamine Hydrochloride (+) Riboflavin) treatment in female patients, resulting in hepatitis acute side effect. The patient was hospitalized.

Cerebral Infarction
This report suggests a potential Alinamin F Cerebral Infarction side effect(s) that can have serious consequences. A female patient (weight: NA) from JAPAN was diagnosed with the following symptoms/conditions: pain,radiculopathy and used Alinamin F (dosage: 12.5 Mg, 2x/day) starting May 27, 2011. Soon after starting Alinamin F the patient began experiencing various side effects, including:
  • Cerebral Infarction
Drugs used concurrently:
  • Pregabalin (25 Mg, 3x/day)
  • Evista (30 Mg, 2x/day)
Although Alinamin F demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as cerebral infarction, may still occur.

Eczema, Seasonal Allergy, Hypersensitivity, Seborrhoeic Dermatitis, Frequent Bowel Movements, Urticaria
This Eczema, Seasonal Allergy, Hypersensitivity, Seborrhoeic Dermatitis, Frequent Bowel Movements, Urticaria problem was reported by a health professional from JAPAN. A 66-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Sep 20, 2007 this consumer started treatment with Alinamin F (dosage: 75 Mg, 1x/day). The following drugs were being taken at the same time:
  • Butenafine Hydrochloride
  • Amlodipine (5 Mg, Daily)
  • Valsartan (80 Mg, 1x/day)
  • Riboflavin Tab (60 Mg, 1x/day)
  • Amlodipine (2.5 Mg, Daily)
When commencing Alinamin F, the patient experienced the following unwanted symptoms/side effects:
  • Eczema
  • Seasonal Allergy
  • Hypersensitivity
  • Seborrhoeic Dermatitis
  • Frequent Bowel Movements
  • Urticaria
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as eczema, may become evident only after a product is in use by the general population.

Abdominal Discomfort, White Blood Cell Count Increased, Pancreatitis, Somnolence, Back Pain, Malaise, Prothrombin Time Prolonged, Anaemia, Hepatic Encephalopathy
This is a report of a 63-year-old male patient (weight: NA) from JAPAN. The patient developed the following symptoms/conditions: hypophagia and was treated with Alinamin F (dosage: Daily Dose 75 Mg) starting Nov 25, 2010. Concurrently used drugs:
  • Nexavar (Daily Dose 600 Mg)
  • Nexavar (400 Mg, Qd)
  • Ve Nicotinate Takeshima (Daily Dose 600 Mg)
  • Bi Love (Daily Dose 40 Mg)
  • Nexavar (Daily Dose 600 Mg)
  • Urso 250 (Daily Dose 300 Mg)
  • Ribovix (Daily Dose 20 Mg)
  • Nexavar (Daily Dose 600 Mg)
Soon after that, the consumer experienced the following side effects:
  • Abdominal Discomfort
  • White Blood Cell Count Increased
  • Pancreatitis
  • Somnolence
  • Back Pain
  • Malaise
  • Prothrombin Time Prolonged
  • Anaemia
  • Hepatic Encephalopathy
This opens a possibility that Alinamin F treatment could cause the above reactions, including abdominal discomfort, and some male subjects may be more susceptible.

Liver Disorder, Hepatic Neoplasm Malignant, Nausea, Rash
A 73-year-old female patient (weight: NA) from JAPAN with the following symptoms/conditions: NA started Alinamin F treatment (dosage: Since Before Administration) on Jun 22, 2009. Soon after starting Alinamin F treatment, the subject experienced various side effects, including:
  • Liver Disorder
  • Hepatic Neoplasm Malignant
  • Nausea
  • Rash
Concurrently used drugs:
  • Livact (Since Before Administration)
  • Aldactone (Since Before Administration)
  • Lendormin (Since Before Administration)
  • Calblock (Since Before Administration)
  • Loxonin (Since Before Administration)
  • Falkamin (Daily Dose 8.3 G)
  • Selbex (Since Before Administration)
  • Nexavar (800 Mg (daily Dose), , Oral)
The patient was hospitalized. This finding indicates that some female patients could be more vulnerable to Alinamin F.

A 83-year-old female patient from JAPAN (weight: NA) experienced symptoms, such as: anxiety disorder,atrial fibrillation,dizziness and was treated with Alinamin F(dosage: 75 Mg, Unk). The treatment was initiated on NS. After that a consumer reported the following side effect(s):
  • Parkinsonism
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Alinamin F efficacy:
  • Sunrythm (100 Mg, 1x/day)
  • Merislon (18 Mg, 1x/day)
  • Brotizolam (0.25 Mg, 1x/day)
  • Amlodipine (5 Mg, Unk)
  • Aspirin (100 Mg, 1x/day)
  • Lipitor (10 Mg, 1x/day)

Hepatic Function Abnormal, Blood Bilirubin Increased
In this report, Alinamin F [fursultiamine] was administered for the following condition: NA.A male consumer from JAPAN (weight: NA) started Alinamin F [fursultiamine] treatment (dosage: Daily Dose 75 Mg) on Jan 24, 2011.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Hepatic Function Abnormal
  • Blood Bilirubin Increased
A possible interaction with other drugs could have contributed to this reaction:
  • Mucosolvan (Daily Dose 45 Mg)
  • Livact (Daily Dose 12.45 Mg)
  • Nexavar (200 Mg, Tid)
  • Urso 250 (Daily Dose 600 Mg)
  • Keratinamin (Unk)
Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Alinamin F [fursultiamine] treatment could be related to the listed above side effect(s).

Loss Of Consciousness
This is a report of the following Alinamin F side effect(s):
  • Loss Of Consciousness
A 77-year-old male patient from JAPAN (weight: NA) presented with the following condition: vitamin b1 deficiency,chronic obstructive pulmonary disease,myocardial infarction and received a treatment with Alinamin F (dosage: Unk) starting: May 15, 2010.The following concurrently used drugs could have generated interactions:
  • Mucodyne (Unk)
  • Aspirin (Unk)
  • Spiriva (Unk)
  • Selbex (Unk)
  • Lanirapid (Unk)
  • Sildenafil Citrate (Unk)
  • Lasix (Unk)
  • Diart
This report suggests that a Alinamin F treatment could be associated with the listed above side effect(s).

Pancreatitis Acute
This Alinamin F report was submitted by a 41-year-old male consumer from JAPAN (weight: NA). The patient was diagnosed with: NA and Alinamin F was administered (dosage: Unk) starting: NS. The consumer developed a set of symptoms:
  • Pancreatitis Acute
Other drugs used simultaneously:
  • Cyanocobalamin (500 Mcg)
  • Meilax (1 Mg)
  • Solanax (1.2 Mg)
  • Depromel (100 Mg)
  • Famotidine (40 Mg)
  • Primperan Tab (10 Mg)
  • Dogmatyl (100 Mg)
  • Zolpidem Tartrate (5 Mg)
The patient was hospitalized.Those unexpected symptoms could be linked to a Alinamin F treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Pancreatitis Acute
This is a report of a possible correlation between Alinamin F use and the following symptoms/side effect(s):
  • Pancreatitis Acute
which could contribute to an assessment of Alinamin F risk profile.A 41-year-old male consumer from JAPAN (weight: NA) was suffering from NA and was treated with Alinamin F (dosage: Unk) starting NS.Other concurrent medications:
  • Cyanocobalamin (500 Mcg)
  • Meilax (1 Mg)
  • Solanax (1.2 Mg)
  • Depromel (100 Mg)
  • Gaster (40 Mg)
  • Primperan Tab (10 Mg)
  • Dogmatyl (100 Mg)
  • Myslee (5 Mg)
The patient was hospitalized.

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Discuss Alinamin F Side Effects

    Did You Have a Alinamin F Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor

    How Effective is Alinamin F for You?

    Exceeded Expectations
    Somewhat Effective
    Not Effective

    Alinamin F Safety Alerts, Active Ingredients, Usage Information

    More About Alinamin f

    Side Effects reported to FDA: 10

    Alinamin F safety alerts: No

    Reported deaths: 2

    Reported hospitalizations: 3

    Latest Alinamin F clinical trials

    Alinamin F Reviews

    No reviews, be a first to report a side effect via side effect reporting form